The Effectiveness of Kinesio® Tex Tape on Gluteus Medius Activation in Dancers

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02741479

Enrollment

Registered

2016-04-18

Start date

2017-01-31

Completion date

2017-12-31

Last updated

2017-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gluteus Medius Activation

Keywords

dancers

Brief summary

The purpose of this research is to determine if a specific type of elasticated athletic tape (Kinesio Tex Tape) increases muscle activation among professional level dancers. Investigators will determine if changes in muscle activation with the elasticated tape differ from changes experienced with no tape and/or sham tape, and if it coincides with subjective sense of muscle activation.

Interventions

OTHERAirplane Test

The airplane test requires the subject to bend forward, bringing the upper body and one leg horizontal, making a T position with the body with the arms out to the sides while in single-leg stance; they then bend the supporting leg, bringing the finger tips towards the floor, followed by straightening the supporting leg and bringing the arms back out to the sides. This motion is repeated five times on each leg per trial. The airplane will be performed to a metronome to standardize performance time

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* Uninjured professional level dancers

Exclusion criteria

* Non-professional level of dance or non-dancer; obesity (body mass index greater than 30 kg/m²) * A history of major back, abdominal, or lower extremity surgery * A history of muscle diseases; a history of serious cardiovascular diseases (e.g., cardiac insufficiency, arrhythmia, severe hypertension, vascular insufficiency) * A history of serious respiratory diseases; major fractures of the lower extremities; lower extremity or trunk injury within the last year; a history of surgery within the last year, a history of stroke, acute, or chronic infections; serious metabolic diseases * Glaucoma * Structural disease or severe congenital deformities of the spine of a high degree * Inguinal, femoral, or umbilical hernia; or diseases related to body equilibrium.

Design outcomes

Primary

Measure	Time frame
Change in Muscle Activity measured via electromyography	Baseline and 1.5 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026